𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer

✍ Scribed by Yasushi Yamada; Masatoshi Watanabe; Mikio Yamanaka; Yoshifumi Hirokawa; Hiroyoshi Suzuki; Akimitsu Takagi; Takeshi Matsuzaki; Yoshiki Sugimura; Ryuichi Yatani; Taizo Shiraishi

Book ID
108582304
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
207 KB
Volume
94
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vascular endothelial growth factor recep
Vascular endothelial growth factor receptor-1 in human cancer : Concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)
✍ Jonathan D. Schwartz; Eric K. Rowinsky; Hagop Youssoufian; Bronislaw Pytowski; Y πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

## Abstract The human vascular endothelial growth factor receptor‐1 (VEGFR‐1, or Flt‐1) is widely expressed in normal and pathologic tissue and contributes to the pathogenesis of both neoplastic and inflammatory diseases. In human cancer, VEGFR‐1 mediated signaling is responsible for both direct tu

Significance of vascular endothelial gro
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer
✍ Masakazu Toi; Hiroko Bando; Taeko Ogawa; Mariko Muta; Carsten Hornig; Herbert A. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 116 KB

## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptor‐1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc